Howard S Hochster/X
Jan 28, 2025, 08:54
Howard S Hochster: Innovative biomarker driven trial in neoadjuvant therapy of gastric cancer
Howard S Hochster, Associate Director for Clinical Research at Rutgers Cancer Institute of New Jersey, shared a post on X:
“Innovative biomarker driven trial in neoadjuvant therapy of gastric cancer. Thanks to PIs Dr Tim Kennedy and Dr Salma Jabbour. Presented at GI25. Thanks to all involved in this outstanding work and Merck for support.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 24, 2025, 13:48
Apr 24, 2025, 13:34
Apr 24, 2025, 12:50
Apr 24, 2025, 12:33
Apr 24, 2025, 12:10
Apr 24, 2025, 11:59
Apr 24, 2025, 11:31